Align Technology, Inc. (ALGN)

Market Cap	9.56B
Revenue (ttm)	3.96B
Net Income (ttm)	437.61M
Shares Out	72.49M
EPS (ttm)	5.92
PE Ratio	22.26
Forward PE	12.49
Dividend	n/a
Ex-Dividend Date	n/a

Volume	757,372
Open	131.76
Previous Close	131.06
Day's Range	131.27 - 133.23
52-Week Range	127.70 - 262.87
Beta	1.65
Analysts	Buy
Price Target	216.25 (+64.05%)
Earnings Date	Oct 22, 2025

About ALGN

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company’s Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. T...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 20,945
• Stock Exchange: NASDAQ
• Ticker Symbol: ALGN
• Website: https://www.aligntech.com

Financial Performance

In 2024, Align Technology's revenue was $4.00 billion, an increase of 3.54% compared to the previous year's $3.86 billion. Earnings were $421.36 million, a decrease of -5.32%.

Analyst Summary

According to 13 analysts, the average rating for ALGN stock is "Buy." The 12-month stock price target is $216.25, which is an increase of 64.05% from the latest price.

Price Target

$216.25

(64.05% upside)

Analyst Consensus: Buy